Australia markets closed

Xenetic Biosciences, Inc. (XBIO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.2700+0.4000 (+10.34%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-4,135
-4,135
-6,552
-5,645
-10,893
Depreciation & amortisation
0
0
27.043
35.482
28.837
Deferred income taxes
-
-
-
0
-2,919
Stock-based compensation
283.085
283.085
511.48
410.437
468.914
Change in working capital
-262.726
-262.726
-426.685
461.193
-52.449
Accounts payable
-263.571
-263.571
-347.947
457.132
-378.111
Other working capital
-4,114
-4,114
-5,147
-4,738
-4,267
Other non-cash items
-
-
1,794
-
-143.639
Net cash provided by operating activities
-4,114
-4,114
-4,647
-4,738
-4,267
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-500
-
-
Net cash used for investing activities
0
0
-500
0
0
Cash flows from financing activities
Common stock issued
-
-
0
11,451
5,427
Net cash used provided by (used for) financing activities
-
-
0
11,455
5,427
Net change in cash
-4,114
-4,114
-5,147
6,716
1,160
Cash at beginning of period
13,097
13,097
18,244
11,528
10,368
Cash at end of period
8,983
8,983
13,097
18,244
11,528
Free cash flow
Operating cash flow
-4,114
-4,114
-4,647
-4,738
-4,267
Capital expenditure
-
-
-500
-
-
Free cash flow
-4,114
-4,114
-5,147
-4,738
-4,267